Cargando…
Influence of antidiabetic medications on predictive aptitude of TyG index for HFpEF
Autores principales: | Shimoda, Tomonari, Imanishi, Ryusuke, Kou, Noriaki, Okamura, Yui, Ito, Hiroshi, Shimojo, Nobutake |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018094/ https://www.ncbi.nlm.nih.gov/pubmed/36588410 http://dx.doi.org/10.1002/clc.23968 |
Ejemplares similares
-
Obesity and HFpEF
por: Clemenza, Francesco, et al.
Publicado: (2022) -
New antidiabetic therapy and HFpEF: light at the end of tunnel?
por: Tadic, Marijana, et al.
Publicado: (2021) -
Focus on HFpEF in heart failure
por: He, Chunhui, et al.
Publicado: (2022) -
Similarities and Differences Between HFmrEF and HFpEF
por: Li, Peixin, et al.
Publicado: (2021) -
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial
por: Borlaug, Barry A., et al.
Publicado: (2023)